Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. Its products include endotoxin activity assay diagnostic and polymyxin b-hemoperfusion therapeutic device. The company was founded on July 29, 1991 and is headquartered in Toronto, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company